SCHEMBL6482055

SCHEMBL6482055

CN(C)c1ccc(C=Cn2cccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.57
APP P05067 6/20 0.53
MAPT P10636 5/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
CASP1 P29466 2/20 0.48
HBB P68871 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
ALOX15 P16050 1/20 0.48
MAT2A P31153 1/20 0.47
KCNH2 Q12809 1/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B3 P37058 1/20 0.47
GAA P10253 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6482052 1.00 RELA (0.57) RELAAPPMAPTMEN1KMT2A
SCHEMBL1714449 0.76 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL1714446 0.76 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL7915381 0.76 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL13467434 0.76 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL3025040 0.76 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL11664007 0.74 MAOB (0.48) RELAMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL29389358 0.74 RELA (0.77) RELAAPPMAPTMEN1KMT2A
SCHEMBL28134823 0.73 TRPA1 (0.57) RELAAPPSMN1; SMN2NPC1RAB9A
SCHEMBL1557244 0.73 RELA (1.00) RELAAPPMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP RELA 3311/4885APP 8/4885MAPT 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.